Gene · 29128
Papers2,616
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,616
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Germline variants in UHRF1 are associated with multilocus imprinting disturbance in humans and mice. | Proc Natl Acad Sci U S A | 2025 | 40825131 | PubTator, text mining | PubMed |
| Mitochondrial fission genes MTFP1/MTFP2 as predictive biomarkers in prostate cancer: a mendelian randomization study. | Discov Oncol | 2025 | 40824549 | PubTator, text mining | PubMed |
| Druggable genome-wide Mendelian randomization integrating GWAS and eQTL/pQTL data identifies targets for lung squamous cell carcinoma. | Sci Rep | 2025 | 40820226 | PubTator, text mining | PubMed |
| Initiation of meiosis from human iPSCs under defined conditions through identification of regulatory factors. | Sci Adv | 2025 | 40815662 | PubTator, text mining | PubMed |
| Identification and validation of hub genes for kidney renal clear cell carcinoma treated with metformin and everolimus combination therapy. | Transl Cancer Res | 2025 | 40792151 | PubTator, text mining | PubMed |
| Integrative analysis identifies FBXO5 as a critical mediator of CRPC progression and bone metastatic potential. | Discov Oncol | 2025 | 40775408 | PubTator, text mining | PubMed |
| The role of epigenetics in pulmonary fibrosis: recent advances in mechanistic insights and therapeutic implications. | Front Mol Biosci | 2025 | 40746422 | PubTator, text mining | PubMed |
| Research on biliary atresia and epigenetic factors from the perspective of transcriptomics: identification of key genes and experimental validation. | Front Pediatr | 2025 | 40746357 | PubTator, text mining | PubMed |
| Epigenetic modifications of gut microbiota and their potential role in atherosclerosis. | Front Pharmacol | 2025 | 40740992 | PubTator, text mining | PubMed |
| Comprehensive review on Fanconi anemia: insights into DNA interstrand cross-links, repair pathways, and associated tumors. | Orphanet J Rare Dis | 2025 | 40739565 | PubTator, text mining | PubMed |
| Removal of promoter CpG methylation by epigenome editing reverses HBG silencing. | Nat Commun | 2025 | 40715076 | PubTator, text mining | PubMed |
| Previously undescribed effects and mechanisms of STAT3 in HPV-induced DNA re-replication in response to DNA damage. | FEBS J | 2025 | 40711991 | PubTator, text mining | PubMed |
| From Lineage to Longevity: A Field Guide to the Key Players in Epigenetic Contribution to Offspring Health. | Curr Issues Mol Biol | 2025 | 40699722 | PubTator, text mining | PubMed |
| UHRF1 in Immune Regulation and Diseases: Mechanisms and Therapeutic Implications. | Clin Rev Allergy Immunol | 2025 | 40694195 | PubTator, text mining | PubMed |
| Development and validation of an MBD3/UHRF1 methylation-regulator-based prognostic model for pancreatic cancer survival. | Transl Cancer Res | 2025 | 40687248 | PubTator, text mining | PubMed |
| The novel ferroptosis-inducing molecule can inhibit the progression of BC by regulating the ubiquitination of UHRF1. | Epigenomics | 2025 | 40667845 | PubTator, text mining | PubMed |
| Molecular mechanisms of maintenance DNA methylation. | Genes Genet Syst | 2025 | 40653371 | PubTator, text mining | PubMed |
| Structures of USP7 in active and inactive states bound to DNMT1 revealed by cryo-EM. | Structure | 2025 | 40645181 | PubTator, text mining | PubMed |
| Targeting Tudor domains in leukemia: epigenetic insights for drug development. | Epigenomics | 2025 | 40622840 | PubTator, text mining | PubMed |
| ANXA1 facilitates myeloid-derived suppressor cell infiltration in the non-small cell lung cancer immunomicroenvironment via the STING/NF-κB/CXCL5/CXCR2 signaling axis to enhance tumor progression. | Biochim Biophys Acta Mol Basis Dis | 2025 | 40617338 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/29128/papers?page=6